SignatureFD’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.76K | Sell |
1,553
-5,837
| -79% | -$6.6K | ﹤0.01% | 2887 |
|
|
2025
Q1 | $10.8K | Buy |
7,390
+5,304
| +254% | +$7.74K | ﹤0.01% | 2310 |
|
|
2024
Q4 | $4.44K | Sell |
2,086
-115
| -5% | -$245 | ﹤0.01% | 2637 |
|
|
2024
Q3 | $6.16K | Buy |
2,201
+1,600
| +266% | +$4.48K | ﹤0.01% | 2502 |
|
|
2024
Q2 | $1.4K | Sell |
601
-3,657
| -86% | -$8.52K | ﹤0.01% | 2828 |
|
|
2024
Q1 | $19K | Buy |
4,258
+106
| +3% | +$474 | ﹤0.01% | 2017 |
|
|
2023
Q4 | $13.3K | Sell |
4,152
-1,798
| -30% | -$5.77K | ﹤0.01% | 2120 |
|
|
2023
Q3 | $18.9K | Buy |
5,950
+2,040
| +52% | +$6.47K | ﹤0.01% | 1873 |
|
|
2023
Q2 | $19.4K | Buy |
3,910
+525
| +16% | +$2.61K | ﹤0.01% | 1902 |
|
|
2023
Q1 | $16.7K | Buy |
3,385
+2,817
| +496% | +$13.9K | ﹤0.01% | 1962 |
|
|
2022
Q4 | $3.57K | Sell |
568
-2,001
| -78% | -$12.6K | ﹤0.01% | 2602 |
|
|
2022
Q3 | $28K | Hold |
2,569
| – | – | ﹤0.01% | 1569 |
|
|
2022
Q2 | $29K | Buy |
2,569
+1,709
| +199% | +$19.3K | ﹤0.01% | 1570 |
|
|
2022
Q1 | $8K | Buy |
860
+831
| +2,866% | +$7.73K | ﹤0.01% | 2232 |
|
|
2021
Q4 | $0 | Sell |
29
-71
| -71% | – | ﹤0.01% | 3089 |
|
|
2021
Q3 | $3K | Buy |
100
+70
| +233% | +$2.1K | ﹤0.01% | 2492 |
|
|
2021
Q2 | $1K | Buy |
30
+3
| +11% | +$100 | ﹤0.01% | 2658 |
|
|
2021
Q1 | $1K | Buy |
+27
| New | +$1K | ﹤0.01% | 2573 |
|
|
2020
Q4 | – | Sell |
-42
| Closed | -$2K | – | 2529 |
|
|
2020
Q3 | $2K | Buy |
+42
| New | +$2K | ﹤0.01% | 2154 |
|
|
2020
Q2 | – | Sell |
-132
| Closed | -$3K | – | 2462 |
|
|
2020
Q1 | $3K | Buy |
+132
| New | +$3K | ﹤0.01% | 1779 |
|